There you go, time to get the payment...
U.S. antitrust regulators cleared General Electric’s biopharma division sale to Danaher Thursday evening. The deal, which will bring $20 billion into GE’s coffers, is now slated to close March 31, in line with management’s expectation.
https://www.barrons.com/articles/ges-20-billion-division-sale-approved-by-regulators-51584663432